0001225208-20-007420.txt : 20200511 0001225208-20-007420.hdr.sgml : 20200511 20200511174028 ACCESSION NUMBER: 0001225208-20-007420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200511 DATE AS OF CHANGE: 20200511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WANG HUIMIN CENTRAL INDEX KEY: 0001204553 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 20866259 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2020-05-11 0001099800 Edwards Lifesciences Corp EW 0001204553 WANG HUIMIN ONE EDWARDS WAY IRVINE CA 92614 1 CVP, Japan & Intercontinental Common Stock 2020-05-11 4 M 0 3883.0000 41.9400 A 36093.9256 D Common Stock 2020-05-11 4 S 0 4.0000 218.7549 D 36089.9256 D Common Stock 2020-05-11 4 S 0 5.0000 219.9595 D 36084.9256 D Common Stock 2020-05-11 4 S 0 10.0000 218.6599 D 36074.9256 D Common Stock 2020-05-11 4 S 0 44.0000 219.0699 D 36030.9256 D Common Stock 2020-05-11 4 S 0 3820.0000 219.0300 D 32210.9256 D Employee Stock Option (Right to Acquire) 41.9400 2020-05-11 4 M 0 3883.0000 0.0000 D 2015-05-08 2021-05-07 Common Stock 3883.0000 34951.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2020-05-11